Back to CYTR Stock Lookup

CytRx (CYTR) – Press Releases

Apr 28, 2016 09:00 AM CytRx to Present at Joseph Gunnar and Co.'s PIONEERS 2016 Investor Conference
Apr 25, 2016 09:00 AM CytRx and PRA Health Sciences Receive Gold Awards for Excellence in Clinical Research as the Strategic Partnership Team of the Year
Apr 20, 2016 09:00 AM CytRx to Present Updated Aldoxorubicin Clinical Trial Data at the American Society of Clinical Oncology Annual Meeting in June 2016
Apr 4, 2016 09:00 AM CytRx Global Pivotal Phase 3 Clinical Trial with Aldoxorubicin Achieves 191 Target Events Triggering Statistical Data Analysis
Mar 22, 2016 09:00 AM CytRx to Present New Data Using Its Proprietary LADRâ„¢ Technology at the 2016 American Association for Cancer Research Annual Meeting
Mar 11, 2016 09:00 AM CytRx Reports 2015 Financial Results
Feb 29, 2016 09:00 AM CytRx to Present at the Cowen & Company's 36th Annual Health Care Conference
Feb 8, 2016 09:00 AM CytRx Secures $40 Million Long-Term Loan Facility
Feb 1, 2016 09:00 AM CytRx to Present at the 18th Annual BIO CEO & Investor Conference
Jan 11, 2016 09:00 AM CytRx Corporation Appoints Olivia Ware as Chief Commercial Officer
Jan 5, 2016 09:00 AM CytRx Announces Settlement of California Stockholder Derivative Lawsuit
Dec 10, 2015 09:00 AM CytRx Announces Settlement of the Consolidated Securities Class Action Lawsuit
Dec 7, 2015 09:00 AM CytRx Nominates Next Clinical Drug Candidate DK049
Dec 3, 2015 09:00 AM CytRx Announces Participation at the 26th Annual Oppenheimer Healthcare Conference
Dec 1, 2015 09:00 AM CytRx Announces the Completion of Enrollment in Pivotal Global Phase 3 Trial Ahead of Schedule
Nov 23, 2015 09:00 AM Aldoxorubicin Continues To Demonstrate Positive Clinical Activity In Phase 2 Glioblastoma Trial
Nov 3, 2015 09:00 AM CytRx Reports 2015 Third Quarter Financial Results
Oct 28, 2015 09:00 AM CytRx to Present Additional Data from its Phase 1b/2 Clinical Trial Combining Aldoxorubicin with Ifosfamide/Mesna at the CTOS 2015 Annual Meeting
Sep 21, 2015 09:00 AM CytRx Announces the Publication of its Positive Global Phase 2b Clinical Trial Results for Soft Tissue Sarcoma in the Peer-Reviewed JAMA Oncology
Sep 3, 2015 09:00 AM CytRx Announces the Presentation of its Phase 2b Clinical Trial Design in Small Cell Lung Cancer at the World Conference on Lung Cancer in Denver, Colorado
Sep 1, 2015 09:00 AM CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference
Aug 3, 2015 09:00 AM CytRx Reports 2015 Second Quarter Financial Results
Jul 24, 2015 11:00 AM CytRx Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Jul 21, 2015 08:45 AM CytRx Announces Pricing of Public Offering of 9.1 Million Shares of Common Stock
Jul 20, 2015 04:01 PM CytRx Announces Proposed Public Offering of Common Stock
Jul 9, 2015 10:00 AM Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
Jun 30, 2015 09:00 AM CytRx Unveils Novel LADRâ„¢ (Linker Activated Drug Release) Technology Platform
Jun 29, 2015 09:00 AM CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma
Jun 24, 2015 09:00 AM Cheryl Cohen, Former Medivation Chief Commercial Officer, Joins CytRx Board of Directors
Jun 2, 2015 09:00 AM CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware
May 27, 2015 09:00 AM CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting
May 26, 2015 09:00 AM CytRx to Present at the Jefferies 2015 Global Healthcare Conference
May 21, 2015 09:00 AM CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer)
May 4, 2015 09:00 AM CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers
May 1, 2015 09:00 AM CytRx Reports First Quarter 2015 Financial Results
Apr 29, 2015 09:00 AM CytRx Announces Publication of Glioblastoma Clinical Case Study in Journal of Nuclear Medicine & Radiation Therapy
Mar 11, 2015 09:00 AM Dr. Anita J. Chawla Joins CytRx Board of Directors to Add Additional Drug Commercialization Expertise in Oncology
Mar 10, 2015 06:00 AM CytRx Reports 2014 Financial Results

Back to CYTR Stock Lookup